The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
about
Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory painRevised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2Pain as a channelopathyPrimary erythromelalgia: a reviewA monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch reliefNeurobiology: a channel sets the gain on painEvidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes.Challenges in the development of novel treatment strategies for neuropathic pain.A nonsense mutation in the SCN9A gene in congenital insensitivity to painA novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockersMutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.Erythema and burning pain in the vulva: a possible phenotype of erythromelalgia.Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgiaToward a Mechanism-Based Approach to Pain Diagnosis.Expression and Role of Voltage-Gated Sodium Channels in Human Dorsal Root Ganglion Neurons with Special Focus on Nav1.7, Species Differences, and Regulation by Paclitaxel.Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies.Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia.
P2860
Q24562888-760F212F-4361-459F-8966-62010A4946B5Q24563738-9247E6B9-A892-4FF0-A0A2-A59306629695Q24622323-41CB12C3-6114-4920-9D35-F6E621A0A846Q26784432-73F960A4-0050-47BE-9A74-32E432E2486AQ28240662-DA35B1F8-15ED-4F79-80E1-24693859F322Q28278802-6EBE0ACF-A4AB-48B5-A2F4-8C0E01CFEEF5Q33819652-CB31C074-CE7B-42D7-B41E-BDF1FE1B2B94Q33947001-FC558E0C-C941-4AA8-81D4-492225B6C8AAQ34263684-1BAF0B06-C1EF-4235-A336-F73A8EA2C773Q34576217-A5DA5F6D-BB3E-4F03-9C06-3DCD4992537DQ34585790-05DDC67C-1F9C-4633-A8A9-9609BA6B4189Q34897090-E9499482-8E26-4428-9565-9CAF9054EC5FQ36727094-DE8E6BCD-5381-445E-BAE3-D15F123CA5C2Q38559303-B9102517-EBAD-4552-8FBC-2970B1BFC4B9Q46380475-ECBB1902-0DE8-4329-AB8F-24897AFB2C25Q47732599-7AE3C3D2-039F-4405-815C-D3D7D46EC54AQ50760625-702C499D-B6AA-44AD-99C9-7EE246AA0D04
P2860
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@ast
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@en
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@nl
type
label
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@ast
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@en
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@nl
prefLabel
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@ast
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@en
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@nl
P2093
P2860
P356
P1476
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.
@en
P2093
Breedveld GJ
Michiels JJ
P2860
P304
P356
10.1086/320107
P407
P577
2001-03-20T00:00:00Z